American Society of Hematology
5-8 December 2020
Featured articles
Editor Prof. Gert Ossenkoppele, Amsterdam UMC, the Netherlands Conference ASH 2020
22 February, 2021 11:58
Presented By Dr Rachel Giles, Medicom Conference ASH 2020
9 December, 2020 14:44
COVID-19
Presented By Dr Susanne Ghandili, University Medical Center Hamburg-Eppendorf, Germany Conference ASH 2020
18 February, 2021 09:34
Presented By Dr Delphine Rea, Université de Paris, France Trial CANDID Conference ASH 2020
18 February, 2021 09:32
Presented By Dr Spyridoula Vasileiou, Baylor College of Medicine, USA Conference ASH 2020
18 February, 2021 09:30
Presented By Prof. William A. Wood, University of North Carolina, USA Conference ASH 2020
18 February, 2021 09:28
Acute Lymphoblastic Leukaemia
Presented By Dr Danielle Fredman, Sheba Medical Center, Israel Conference ASH 2020
18 February, 2021 09:26
Presented By Dr Lori Muffly, Stanford University, California, USA Conference ASH 2020
18 February, 2021 09:24
Presented By Prof. Sebastian Giebel, Maria Skłodowska-Curie National Research Institute of Oncology, Poland Conference ASH 2020
18 February, 2021 09:23
Acute Myeloid Leukaemia
Presented By Dr Shannon Murphy, Dalhousie University, Canada Conference ASH 2020
18 February, 2021 09:21
Presented By Dr Shukaib Arslan, City Of Hope Helford Clinical Research Hospital, California, USA Conference ASH 2020
18 February, 2021 09:19
Presented By Ms Jacqueline S. Garcia, Dana-Farber Institute, Massachusetts, USA Conference ASH 2020
18 February, 2021 09:18
Presented By Dr Maximilian Stahl, Memorial Sloan Kettering Cancer Center, New York, USA Conference ASH 2020
18 February, 2021 09:15
Presented By Dr Alexander Perl, University of Pennsylvania, USA Trial Phase 3, QuANTUM-R Conference ASH 2020
18 February, 2021 09:14
Presented By Dr David Sallman, H. Lee Moffitt Cancer Center and Research Institute, Florida, USA Trial Phase 1 Conference ASH 2020
18 February, 2021 09:11
Presented By Dr Ibrahim Aldoss, City of Hope Medical Center, California, USA Trial Phase 1/2 Conference ASH 2020
18 February, 2021 09:09
Presented By Dr Alexander Perl, University of Pennsylvania, USA Trial CHRYSALIS, ADMIRAL Conference ASH 2020
18 February, 2021 09:07
Presented By Dr Tapan Kadia, MD Anderson Cancer Center, Texas, USA Conference ASH 2020
18 February, 2021 09:05
Chronic Leukaemia
Presented By Prof. Tim Brümmendorf, RWTH Aachen University, Germany Trial Phase 3, BFORE Conference ASH 2020
18 February, 2021 09:17
Presented By Dr Hagop Kantarjian, MD Anderson Cancer Center, Texas, USA Trial OPTIC, PACE Conference ASH 2020
18 February, 2021 09:08
Presented By Dr Andreas Hochhaus, Universitätsklinikum Jena, Germany Trial Phase 3, ASCEMBL Conference ASH 2020
18 February, 2021 08:58
Presented By Prof. Jan Burger, MD Anderson Cancer Center, Texas, USA Trial Phase 3, RESONATE-2, iLLUMINATE Conference ASH 2020
18 February, 2021 08:54
Multiple Myeloma
Presented By Dr Angelo Belotti, ASST Spedali Civili di Brescia, Italy Conference ASH 2020
18 February, 2021 10:43
Presented By Dr Hira Mian, McMaster University, Canada Conference ASH 2020
18 February, 2021 10:42
Presented By Prof. Thierry Facon, University Hospital Lille, France Trial Phase 3, TOURMALINE-MM2 Conference ASH 2020
18 February, 2021 10:37
Presented By Dr Francesca Gay, GIMEMA, European Myeloma Network, Italy Trial Phase 2, FORTE Conference ASH 2020
18 February, 2021 10:35
Presented By Prof. Michele Cavo, University of Bologna, Italy Trial Phase 3, EMN02/HO95 Conference ASH 2020
18 February, 2021 10:29
Presented By Prof. Meletios Dimopoulos, University of Athens, Greece Trial Phase 3, APOLLO Conference ASH 2020
18 February, 2021 10:26
Presented By Dr Enrique Ocio, University Hospital Marqués de Valdecilla, Spain Trial Phase 1/2, ANCHOR (OP-104) Conference ASH 2020
18 February, 2021 10:22
Presented By Dr Adam Cohen, University of Pennsylvania, Philadelphia, USA Trial Phase 1, GO39775 Conference ASH 2020
18 February, 2021 10:20
Presented By Dr Yi Lin, Mayo Clinic, Minnesota, USA Trial Phase 1, CRB-401 Conference ASH 2020
18 February, 2021 10:17
Lymphoma
Presented By Dr Robbie Majzner, Stanford University, California, USA Conference ASH 2020
18 February, 2021 10:15
Presented By Dr Caron Jacobson, Dana Farber Cancer Institute, Massachusetts, USA Trial Phase 2, ZUMA-5 Conference ASH 2020
18 February, 2021 10:12
Myeloproliferative Neoplasms
Presented By Dr Rami S. Komrokji (H. Lee Moffitt Cancer Center and Research Institute, Florida, USA) & Dr Michael R. Grunwald (Levine Cancer Institute, North Carolina, USA) Trial MOST Conference ASH 2020
18 February, 2021 10:08
Presented By Dr Srdan Verstovsek, MD Anderson Cancer Center, Texas, USA Trial SIMPLIFY Conference ASH 2020
18 February, 2021 10:05
Presented By Dr Naveen Pemmaraju, MD Anderson Cancer Center, Texas, USA Conference ASH 2020
18 February, 2021 09:59
Presented By Dr Jyoti Nangalia, University of Cambridge, United Kingdom Conference ASH 2020
18 February, 2021 09:53
Immune Thrombocytopenia
Presented By Dr Charlotte Bradbury, University of Bristol, United Kingdom Trial FLIGHT Conference ASH 2020
18 February, 2021 09:50
Presented By Dr Catherine Broome, MedStar Georgetown University Hospital, Washington DC, USA Trial Phase 1 Conference ASH 2020
18 February, 2021 09:46
Presented By Dr David J. Kuter, Massachusetts General Hospital & Harvard Medical School, USA Conference ASH 2020
18 February, 2021 09:42
Haemophilia, Sickle Cell Disease, Thalassaemia
Presented By Prof. Steven Pipe, University of Michigan, USA Trial Phase 3, HOPE-B Conference ASH 2020
18 February, 2021 08:25
Presented By Dr Kate Khair, Great Ormond Street Hospital for Children, UK Trial CHESS Paediatrics Conference ASH 2020
18 February, 2021 08:22
Presented By Dr Haydar Frangoul, Sarah Cannon Research Institute, USA Trial CLIMB THAL-111 & CLIMB SCD-121 Conference ASH 2020
18 February, 2021 08:18
Presented By Prof. Olivier Hermine, Université de Paris, France Trial Phase 3, BELIEVE Conference ASH 2020
18 February, 2021 08:12
